124 related articles for article (PubMed ID: 34958275)
1. Epitope Mapping of an Anti-HER2 Monoclonal Antibody (H
Asano T; Takei J; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Dec; 40(6):255-260. PubMed ID: 34958275
[TBL] [Abstract][Full Text] [Related]
2. Development of a Novel Anti-HER2 Monoclonal Antibody H
Takei J; Asano T; Tanaka T; Sano M; Hosono H; Nanamiya R; Tateyama N; Saito M; Suzuki H; Harada H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):168-176. PubMed ID: 34424764
[TBL] [Abstract][Full Text] [Related]
3. Development of an Anti-HER2 Monoclonal Antibody H2Mab-139 Against Colon Cancer.
Kaneko MK; Yamada S; Itai S; Kato Y
Monoclon Antib Immunodiagn Immunother; 2018 Feb; 37(1):59-62. PubMed ID: 29315012
[TBL] [Abstract][Full Text] [Related]
4. Establishment of H
Yamada S; Itai S; Nakamura T; Chang YW; Harada H; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):287-290. PubMed ID: 29172998
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H
Kaneko MK; Suzuki H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):35-43. PubMed ID: 38563783
[TBL] [Abstract][Full Text] [Related]
6. H
Itai S; Fujii Y; Kaneko MK; Yamada S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Takahashi M; Suzuki H; Harada H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):143-148. PubMed ID: 28700270
[TBL] [Abstract][Full Text] [Related]
7. An Antihuman Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H
Kato Y; Ohishi T; Takei J; Nakamura T; Kawada M; Kaneko MK
Monoclon Antib Immunodiagn Immunother; 2020 Aug; 39(4):135-139. PubMed ID: 32644843
[TBL] [Abstract][Full Text] [Related]
8. An Anti-HER2 Monoclonal Antibody H
Tateyama N; Asano T; Ohishi T; Takei J; Hosono H; Nanamiya R; Tanaka T; Sano M; Saito M; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):184-190. PubMed ID: 34424760
[TBL] [Abstract][Full Text] [Related]
9. Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H
Kato Y; Ohishi T; Yamada S; Itai S; Takei J; Sano M; Nakamura T; Harada H; Kawada M; Kaneko MK
Monoclon Antib Immunodiagn Immunother; 2019 Aug; 38(4):157-161. PubMed ID: 31199696
[TBL] [Abstract][Full Text] [Related]
10. An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H
Kato Y; Ohishi T; Takei J; Nakamura T; Sano M; Asano T; Sayama Y; Hosono H; Kawada M; Kaneko MK
Monoclon Antib Immunodiagn Immunother; 2020 Aug; 39(4):123-128. PubMed ID: 32552424
[TBL] [Abstract][Full Text] [Related]
11. H
Kato Y; Ohishi T; Sano M; Asano T; Sayama Y; Takei J; Kawada M; Kaneko MK
Monoclon Antib Immunodiagn Immunother; 2020 Jun; 39(3):61-65. PubMed ID: 32423281
[TBL] [Abstract][Full Text] [Related]
12. Defucosylated Monoclonal Antibody (H
Suzuki H; Ohishi T; Nanamiya R; Kawada M; Kaneko MK; Kato Y
Curr Issues Mol Biol; 2023 Sep; 45(10):7734-7748. PubMed ID: 37886932
[TBL] [Abstract][Full Text] [Related]
13. H
Takei J; Kaneko MK; Ohishi T; Kawada M; Harada H; Kato Y
Exp Ther Med; 2020 Aug; 20(2):846-853. PubMed ID: 32765652
[TBL] [Abstract][Full Text] [Related]
14. Epitope Mapping of an Anti-CD20 Monoclonal Antibody (C
Takei J; Suzuki H; Asano T; Li G; Saito M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Dec; 40(6):250-254. PubMed ID: 34958272
[TBL] [Abstract][Full Text] [Related]
15. Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies.
Arimori T; Mihara E; Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Takagi J; Kato Y
Structure; 2024 May; 32(5):536-549.e5. PubMed ID: 38460519
[TBL] [Abstract][Full Text] [Related]
16. Epitope Mapping of an Anti-CD10 Monoclonal Antibody (MME/1870) Using Enzyme-Linked Immunosorbent Assay.
Kawabata H; Suzuki H; Takei J; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Feb; 41(1):15-19. PubMed ID: 35225664
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to HER2 extracellular domain and subdomains in mouse following DNA immunization.
Sadri-Ardalani F; Shabani M; Amiri MM; Bahadori M; Emami S; Sarrafzadeh AR; Noutash-Haghighat F; Jeddi-Tehrani M; Shokri F
Tumour Biol; 2016 Jan; 37(1):1217-27. PubMed ID: 26282003
[TBL] [Abstract][Full Text] [Related]
18. Epitope Mapping of an Anti-elephant Podoplanin Monoclonal Antibody (PMab-295) Using Enzyme-Linked Immunosorbent Assay.
Okada Y; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Aug; 41(4):221-227. PubMed ID: 35917553
[TBL] [Abstract][Full Text] [Related]
19. Epitope Mapping of an Anti-Human CCR9 Monoclonal Antibody (C
Takei J; Asano T; Li G; Saito M; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Dec; 40(6):239-242. PubMed ID: 34958276
[TBL] [Abstract][Full Text] [Related]
20. Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α.
Ceran C; Cokol M; Cingoz S; Tasan I; Ozturk M; Yagci T
BMC Cancer; 2012 Oct; 12():450. PubMed ID: 23033967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
